Post-shunt resource consumption favors small-diameter prosthetic H-graft portacaval shunt over TIPS for patients with poor hepatic reserve
- PMID: 12796578
- PMCID: PMC1514681
- DOI: 10.1097/01.SLA.0000072102.38993.05
Post-shunt resource consumption favors small-diameter prosthetic H-graft portacaval shunt over TIPS for patients with poor hepatic reserve
Abstract
Objective: To define the role of surgical shunting for patients with poor hepatic reserve (Child's class C) in the era of TIPS.
Summary background data: Most physicians prefer TIPS to surgical shunting for patients with poor hepatic reserve because of anticipated poor long-term survival.
Methods: Sixty-two patients of Child's class C with bleeding varices not amenable to endoscopic sclerotherapy or banding were prospectively randomized to undergo TIPS or 8-mm prosthetic H-graft portacaval shunt (HGPCS) from 1993 to 1999. Resource consumption and survival after shunting were determined.
Results: Twenty-nine patients underwent TIPS and 33 underwent HGPCS. After HGPCS, survival at 3 years was favorable but not statistically superior. TIPS was more often associated with shunt stenoses/occlusions, recurrent hemorrhage, shunt revisions, and shunt failure. Long-term follow-up documented that after HGPCS, patients required fewer hospital and ICU days and fewer units of RBCs transfused. After HGPCS, cost of care was less, as was the median cost of care per day of survival.
Conclusions: For Child's class C patients undergoing HGPCS or TIPS, long-term survival is similar, though favoring HGPCS. Similarly, measures of resource consumption and cost of care following hospital discharge favor HGPCS. HGPCS should be preferentially applied for acceptable patients without access to convenient capable post-shunt care or without definitive plans for imminent transplantation.
Similar articles
-
Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial.J Am Coll Surg. 2012 Apr;214(4):445-53; discussion 453-5. doi: 10.1016/j.jamcollsurg.2011.12.042. J Am Coll Surg. 2012. PMID: 22463885 Clinical Trial.
-
Differential effects on portal and effective hepatic blood flow. A comparison between transjugular intrahepatic portasystemic shunt and small-diameter H-graft portacaval shunt.Ann Surg. 1997 May;225(5):601-7; discussion 607-8. doi: 10.1097/00000658-199705000-00016. Ann Surg. 1997. PMID: 9193187 Free PMC article. Clinical Trial.
-
H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals.Ann Surg. 2005 Feb;241(2):238-46. doi: 10.1097/01.sla.0000151884.67600.b6. Ann Surg. 2005. PMID: 15650633 Free PMC article.
-
Transjugular intrahepatic portosystemic shunt in the prevention of rebleeding in oesophageal varices.Eur J Gastroenterol Hepatol. 2006 Nov;18(11):1167-71. doi: 10.1097/01.meg.0000236873.67977.98. Eur J Gastroenterol Hepatol. 2006. PMID: 17033436 Review.
-
[Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].Zentralbl Chir. 2005 Jun;130(3):246-9. doi: 10.1055/s-2005-836547. Zentralbl Chir. 2005. PMID: 15965878 Review. German.
Cited by
-
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Mar 30;3(3):CD013122. doi: 10.1002/14651858.CD013122.pub2. Cochrane Database Syst Rev. 2021. PMID: 33784794 Free PMC article.
-
[Portosystemic shunt surgery between TIPS and liver transplantation].Chirurg. 2011 Oct;82(10):898-905. doi: 10.1007/s00104-011-2100-1. Chirurg. 2011. PMID: 21932152 Review. German.
-
Current role of surgery in portal hypertension.Indian J Surg. 2012 Feb;74(1):55-66. doi: 10.1007/s12262-011-0381-8. Epub 2011 Dec 13. Indian J Surg. 2012. PMID: 23372308 Free PMC article.
-
Conventional predictors of survival poorly predict and significantly underpredict survival after H-graft portacaval shunts.J Gastrointest Surg. 2007 Jan;11(1):89-94. doi: 10.1007/s11605-006-0041-7. J Gastrointest Surg. 2007. PMID: 17390193
-
Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.Cochrane Database Syst Rev. 2018 Oct 31;10(10):CD001023. doi: 10.1002/14651858.CD001023.pub3. Cochrane Database Syst Rev. 2018. PMID: 30378107 Free PMC article.
References
-
- Zemel G, et al. Percutaneous transjugular portosystemic shunt. JAMA. 1991; 266: 390–393. - PubMed
-
- Conn H. Transjugular intrahepatic portal-systemic shunts: the state of the art. Hepatology. 1993; 17: 148–158. - PubMed
-
- Rossle M, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med. 1994; 330: 165–171. - PubMed
-
- Kuhlman CG, et al. Use of balloon-expandable stents in transjugular intrahepatic portosystemic shunts in cases of Wallstent endoprosthesis technical failure and revision of shunt stenosis. J Vasc Interv Radiol. 2002; 13: 405–408. - PubMed
-
- Sanyal AJ, Freedman AM, Luketic VA, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology. 1997; 112: 889–898. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical